Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
27 studies found for:    " October 03, 2007":" November 02, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" October 03, 2007":" November 02, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (27 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed
Has Results
TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.
Conditions: HIV Infections;   HIV-1;   Human Immunodeficiency Virus Type 1
Interventions: Drug: TMC278;   Drug: efavirenz
2 Completed Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients
Conditions: Human Immunodeficiency Viruses;   Kidney Failure;   HIV Infections
Intervention:
3 Completed
Has Results
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir/lamivudine and efavirenz;   Drug: Tenofovir/Emtricitabine and efavirenz
4 Completed
Has Results
TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Conditions: HIV Infections;   HIV-1
Interventions: Drug: TMC278;   Drug: efavirenz
5 Completed Motivation and Patch Treatment for HIV-Positive Smokers
Conditions: HIV Infections;   Smoking Cessation
Interventions: Behavioral: Standard Care;   Behavioral: Motivational Enhancement
6 Completed Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers
Condition: HIV Infections
Interventions: Device: TriGrid™ Delivery System;   Device: conventional intramuscular injection
7 Completed Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence
Conditions: Opiate Dependence;   HIV Infections
Interventions: Behavioral: Enhanced Sexual Risk Management;   Behavioral: Standard Sexual Risk Management
8 Completed Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDS
Condition: HIV Infections
Intervention:
9 Completed Rapid HIV Testing Program in the Emergency Department
Condition: HIV Infections
Intervention: Other: HIV test by oral swab
10 Completed Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.
Conditions: Hypertriglyceridemia;   HIV Infections
Intervention: Dietary Supplement: soluble fiber® (partially hydrolyzed guar gum)
11 Completed Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Vicriviroc;   Drug: Placebo
12 Completed Pediatric Expanded Access Program-Oral Solution
Condition: HIV Infections
Intervention: Drug: MK0831
13 Completed A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults
Condition: HIV Infections
Intervention: Other: Sutherlandia
14 Unknown  The Role of Diet Education and Nutritional Counselling in the Ongoing Care of People Living With HIV in Thailand
Condition: HIV Infections
Intervention: Behavioral: Nutrition Counselling
15 Unknown  Diagnosis of Tuberculosis Infection in HIV Co-infected Children
Conditions: Latent Tuberculosis Infection;   Tuberculosis;   HIV Infections
Intervention:
16 Unknown  Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
17 Completed A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)
Condition: HIV Infections
Interventions: Drug: MK0639, indinavir sulfate / Duration of Treatment: 48 Weeks;   Drug: Comparator: nelfinavir mesylate / Duration of Treatment: 48 Weeks
18 Completed
Has Results
Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence
Condition: HIV Infections
Interventions: Procedure: Acupuncture;   Behavioral: Relaxation Response;   Other: sham acupuncture
19 Completed
Has Results
Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors
Condition: HIV Infections
Interventions: Drug: Darunavir (DRV/r);   Drug: continue on current dual boosted PI
20 Completed The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects
Condition: HIV Infections
Interventions: Drug: nevirapine;   Drug: atazanavir/ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years